Tirzepatide

Better GLP-1 stock to buy: Eli Lilly or Viking therapeutics? The Motley Fool20:51Mounjaro Eli Lilly Pharma

Eli Lilly raises 2026 outlook again as Q2 soars past estimates Pharmaceutical Technology11:19Mounjaro Eli Lilly Pharma

Memorial doctor discusses benefits, risks of GLP-1 weight loss medications WLOX15:00

'Do not buy this product' Dr Amir Khan weight loss drug warning message The Mirror09:53

Hometown health: GLP-1 drug, “Tirzepatide”, linked to lower heart attack risk in high-risk patients WDBJ714:52Mounjaro Heart Disease Diabetes

GLP-1 drug linked to heart benefits for high-risk patients HumanProgress18:23Mounjaro Heart Disease Diabetes

Mounjaro sales double this year as obesity drug boom prevails, says maker Evening Standard13:44Mounjaro Eli Lilly Obesity

Sales in weight-loss drug Mounjaro double amid surging market appetite The Independent14:38Mounjaro Eli Lilly Obesity

Does GLP-1 drug tirzepatide trigger hair loss? Experts weigh in. Allure22:15Ozempic Mounjaro Global Health

GLP-1 drugs may have a hidden effect on your eyes, study finds ScienceAlert06:09Ozempic Mounjaro Global Health

Shifting GLP-1 research and development: Lessons learned from the first-generation Drug Discovery & Development18:15Pharma Mounjaro

Bariatric surgery remains an important option for obesity, despite GLP-1 drug boom Medpage Today14:35Diet and Fitness

Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns Pharmaceutical Technology12:39Diet and Fitness

Bank of America spends $250m a year on employee weight loss drugs Personnel Today10:36Bank of America World Banking Diet and Fitness

Decision on publicly funded weight-loss drugs in Jersey delayed Jersey Evening Post09:52Obesity NHS Diet and Fitness

Could GLP-1 drugs help treat psoriasis? Here’s what the Science says Health Magazine17:43Obesity Global Health

Latest News

In the last 4 hours

Investigation: Social media, anonymous websites drive Nigeria’s poorly regulated weight-loss… Premium Times, Nigeria05:05

Earlier today

How weight-loss medication is changing relationships with alcohol BBC00:34

Yesterday

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics? The Motley Fool20:51 8-Aug-26

Memorial doctor discusses benefits, risks of GLP-1 weight loss medications WLOX15:00 8-Aug-26

Mounjaro use investigated after woman dies suddenly following increasing dosage Swindon Advertiser10:51 8-Aug-26

Will the NHS get serious about prescribing weight loss drugs? The Spectator06:56 8-Aug-26

In the last 7 days

Eli Lilly Launches Attacks Of Tirzepatide Generics Law36021:06 7-Aug-26

GLP-1 Drug Linked to Heart Benefits for High-Risk Patients HumanProgress18:23 7-Aug-26

Shifting GLP-1 research and development: Lessons learned from the first-generation Drug Discovery & Development18:15 7-Aug-26

Urgent warning after over 200 deaths linked to weight loss jabs Witney Gazette16:03 7-Aug-26

Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD HealthDay15:16 7-Aug-26

Gedeon Richter Bets on the Billion-Dollar Weight-Loss Drug Market Hungary Today15:01 7-Aug-26

Could Newest Diabetes Drug Protect the Heart? Knowridge Science Report11:05 7-Aug-26

Bank of America spends $250m a year on employee weight loss drugs Personnel Today10:36 7-Aug-26

Dubai resident feels weight lifted from shoulders after pioneering procedure helps her shed 19kg The National09:03 7-Aug-26

New review links obesity with accelerated biological aging mechanisms News-Medical.Net03:07 7-Aug-26

Above the Federal Floor: How States Are Regulating Compounded GLP-1s and Peptides National Law Review22:46 6-Aug-26

More than 200 deaths with suspected links to weight loss jabs reported to watchdog The Mirror16:48 6-Aug-26

More than 150 deaths reported after weight loss drug use The Independent16:45 6-Aug-26

Eli Lilly Earnings: Strong Q2 and Higher Margin Expectations MorningStar.com15:39 6-Aug-26

expert reaction to reports of numbers of deaths after use of obesity drugs, as first reported in the Times Science Media Centre15:02 6-Aug-26

Hometown health: GLP-1 drug, “Tirzepatide”, linked to lower heart attack risk in high-risk patients WDBJ714:52 6-Aug-26

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit pharmaphorum13:56 6-Aug-26

Eli Lilly raises 2026 outlook again as Q2 soars past estimates Pharmaceutical Technology11:19 6-Aug-26

New update 'links more than 200 deaths' to weight loss jabs Teesside Live11:18 6-Aug-26

Weight loss jabs 'linked to more than 200 deaths' in new figures Essex Live11:03 6-Aug-26

'Do not buy this product' Dr Amir Khan weight loss drug warning message The Mirror09:53 6-Aug-26

Group of people taking Mounjaro '33pc less likely to have heart attack' North Wales Live06:32 6-Aug-26

People with type 2 diabetes and heart disease taking Mounjaro '33pc less likely to have heart… Plymouth Live06:26 6-Aug-26

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events News-Medical.Net05:03 6-Aug-26

Shock 216 UK deaths and 18,000 severe reactions linked to weight loss jabs - fatalities surge… MailOnline02:11 6-Aug-26

Does GLP-1 Drug Tirzepatide Trigger Hair Loss? Experts Weigh In. Allure22:15 5-Aug-26

Revive Rx Can't End Eli Lilly's Suit Over Tirzepatide Drugs Law36020:24 5-Aug-26

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says Pharmaceutical Technology17:22 5-Aug-26

Eli Lilly stock surges 6% after Q2 earnings beat driven by Mounjaro, Zepbound Invezz15:30 5-Aug-26

Sales in weight-loss drug Mounjaro double amid surging market appetite The Independent14:38 5-Aug-26

Mounjaro sales double this year as obesity drug boom prevails, says maker Evening Standard13:44 5-Aug-26

Lilly's GLP-1s race away in Q2, though Foundayo falls short pharmaphorum13:40 5-Aug-26

Novo fails to shrug off investor concern at Q2 update pharmaphorum11:48 5-Aug-26

GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds ScienceAlert06:09 5-Aug-26

Childhood obesity: The growing health challenge demands early action Qatar Tribune22:43 4-Aug-26

ADA Reviewing Police Tussle; Obesity Trial Lawsuit; Retatrutide's Early Access Medpage Today19:58 4-Aug-26

Impact of USPTO Directors Stewart and Squires on Pharmaceutical Patent Challenges at the PTAB JD Supra18:58 4-Aug-26

Could GLP-1 Drugs Help Treat Psoriasis? Here’s What the Science Says Health Magazine17:43 4-Aug-26

What Is ‘Ozempic Hair’? Experts Explain the GLP-1 Side Effect Elle17:28 4-Aug-26

ACC Releases 2026 Expert Consensus Decision Pathway on HFpEF The Cardiology Advisor15:03 4-Aug-26

Eli Lilly Is Up 7% in 2026 and Has Major Catalysts on the Way. Is the Rally Just Getting Started? The Motley Fool12:47 4-Aug-26

Best Protein Sources for GLP-1 Users, Per an R.D. Prevention.com12:40 4-Aug-26

5 Hidden Side Effects Of GLP-1s To Consider Before Treatment Forbes11:05 4-Aug-26

Decision on publicly funded weight-loss drugs in Jersey delayed Jersey Evening Post09:52 4-Aug-26

‘Ozempic hair’ is the latest side effect linked to weight loss jabs Metro.co.uk07:20 4-Aug-26

Ozempic Face and Ozempic Body: The Complete Evidence-Based Guide to Causes, Prevention,… Dibesity06:32 4-Aug-26

Comedian-actress Amy Schumer shows off fit frame on Instagram Canoe21:25 3-Aug-26

Bariatric Surgery Remains an Important Option for Obesity, Despite GLP-1 Drug Boom Medpage Today14:35 3-Aug-26

Your Labs Say Normal, Your Body Says Otherwise: Here Is What’s Really Going On Thrive Global14:11 3-Aug-26

After The Weight Loss: What Happens When Patients Stop GLP-1 Medications? The Dallas Express14:01 3-Aug-26

Andrew Ambrosy, Top Heart Doctor, Highlights GLP-1 and Dual Gip/GLP-1 Use for Lowering Risk of… PR Newswire (Press Release)14:00 3-Aug-26

Six Indicted in Czech $20M VAT Fraud Case OCCRP12:37 3-Aug-26

Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and… PR Newswire (Press Release)11:57 3-Aug-26

This Next-Gen GLP-1 Is Blowing Up the Black Market Economy Marie Claire11:10 3-Aug-26

GLP-1 drugs like Ozempic might help clear Alzheimer’s disease plaques, new review suggests PsyPost23:07 2-Aug-26

'It gives people more time to think': The strange effect of GLP-1s that's puzzling experts BBC Science Focus10:13 2-Aug-26

Your collagen is in the kitchen. And it’s better than the best anti-ageing skincare routine ThePrint06:17 2-Aug-26

In the last month

Prediction: Eli Lilly Will Be Worth $2 Trillion by 2031 The Motley Fool21:21 1-Aug-26

Rapid drug-induced weight loss may trigger hair fall, warn doctors The Times of India20:06 1-Aug-26

Medicare’s GLP-1 Bridge Program Offers Access, But Isn’t Straightforward Forbes19:49 1-Aug-26

Novo Nordisk Shares Plunge After a Key Trial Fails. Should Investors Buy the Dip? The Motley Fool22:27 31-Jul-26

Biohackers Think Retatrutide Will Be Bigger Than Ozempic. Does the Science Check Out? Elle18:45 31-Jul-26

Slim Shady: Smugglers Eye Big Profits Running Weight Loss Drugs into Brazil OCCRP17:49 31-Jul-26

Novo Nordisk Says Anti-Inflammatory Drug Trial Fails to Cut Cardiovascular Risk in High Risk Patients Benzinga14:33 31-Jul-26

Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns Pharmaceutical Technology12:39 31-Jul-26

Apnimed IPO raises $192m, as three other biotechs set terms pharmaphorum10:52 31-Jul-26

The same 10mg Zepbound costs $449 or $699 The Health Care Blog00:24 31-Jul-26

A Daily GLP-1 Pill Could Curb Heavy Drinking Gizmodo17:45 30-Jul-26

India’s generic GLP-1 drugs are (mostly) booming Chemistry World Magazine14:34 30-Jul-26

Women say they got pregnant after taking GLP-1 drugs ABC News13:24 30-Jul-26

Peptides for weight loss: Are they safe and how do they work? GMA News01:02 30-Jul-26

Desperate Ozempic users turn to dangerous 'mixing' to maximize results... but doctors sound… MailOnline23:43 29-Jul-26

Scientists Find Unexpected Benefit of Weight Loss Drugs Knowridge Science Report21:05 29-Jul-26

Florida Warns on Psych Meds in Kids; Binge Drinking While Pregnant; ADHD in Females Medpage Today19:40 29-Jul-26

Fauci Invokes 5th Amendment; Medicare Subsidies to End; Blood Supply Crisis Medpage Today14:34 29-Jul-26

Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz Swiss Info13:40 29-Jul-26

Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock The Motley Fool13:29 29-Jul-26

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming … The Motley Fool12:59 29-Jul-26

MHRA highlights weight loss pitfalls amid continuing GLP-1 demand Nursing in Practice10:13 29-Jul-26

US judge says Novo Nordisk must face lawsuit over CagriSema pharmaphorum10:00 29-Jul-26

Koreans in their 20s and 30s account for over half of Mounjaro prescription checks Korea Biomedical Review09:24 29-Jul-26

Prescription weight-loss injections: Who are they for and how do they work? The Straits Times21:10 28-Jul-26

Thyroid Meds Recalled Nationwide; Worst GLP-1 for Hair Loss? PMOS Prevalence Medpage Today20:16 28-Jul-26

Rosie O’Donnell Shares Future GLP-1 Plans, Says ‘Quick’ Weight Loss ‘Overwhelms Me’ People18:33 28-Jul-26

Rosie O'Donnell reveals how she avoided side effects during 65lb Mounjaro weight loss MailOnline18:16 28-Jul-26

Here's How LLY's Non-GLP-1 Portfolio Is Poised Ahead of Q2 Earnings Zacks17:23 28-Jul-26

Peptides: With Talk Of Looser Restrictions In The US, We Ask If There's A Dark Side To The Internet's Latest Wellness… IFLScience16:43 28-Jul-26

Vizient Projects 3.54% Pharmacy Inflation and 4.73% Indirect Spend Inflation for 2027 Business Wire (Press Release)15:53 28-Jul-26

Where Will Novo Nordisk Stock Be in 3 Years? The Motley Fool14:03 28-Jul-26

Parker Waichman Applauds Health Canada and Australia for Strengthening Naion Safety Guidance… PR Newswire (Press Release)13:15 28-Jul-26

Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development Pharmaceutical Technology12:04 28-Jul-26

Could Diabetes and Weight Loss drugs Help Fight Alcohol Addiction? Knowridge Science Report12:01 28-Jul-26

GLP-1 medications reduced the number of bariatric surgeries Verdict Medical Devices11:08 28-Jul-26

Scribe raises $155m in IPO, as Apnimed pitches for $150m pharmaphorum11:00 28-Jul-26

Weight-Loss Drugs May Fight Harmful Inflammation Knowridge Science Report01:54 28-Jul-26

Medicare Pays Billions For Obesity’s Consequences. Its GLP-1 Bridge Offers A Better Way Forbes13:28 27-Jul-26

Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/Gipr/Gcgr Triple Peptide… PR Newswire (Press Release)11:13 27-Jul-26

Study shows how GLP-1 obesity drugs are associated with reduced systemic inflammation beyond their anti-obesity effects World Obesity Federation10:29 27-Jul-26

GLP-1s May Help You Stop Biting Your Nails—Here's Why Allure15:11 25-Jul-26

Novo Nordisk Doubles Down On Efforts To Halt Lilly Tirzepatide Ads Scrip Pharma Intelligence22:37 24-Jul-26

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? The Motley Fool18:08 24-Jul-26

Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 Manufacturing Chemist15:15 24-Jul-26

Weekly Dose of Optimism #194 Not Boring13:24 24-Jul-26

Dr Amir Khan discusses how to prevent hair loss on weight loss jabs Belfast Live12:33 24-Jul-26

Dr Amir's hair loss advice for anyone taking weight loss medications Plymouth Live12:22 24-Jul-26

No Summer Shortcut for Safe Weight Loss GOV.UK (Press Release)10:52 24-Jul-26

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits News-Medical.Net07:32 24-Jul-26

Tga issues warning over rare eye disorder linked to Ozempic-like drugs ABC Online02:19 24-Jul-26

Hair Loss May Be a New Potential Side Effect of GLP-1 Weight Loss Drugs Discover Magazine22:22 23-Jul-26

view more headlines

9 Aug 05:05

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.